Prevalence of Multidrug Resistant Micro-organism Carriage in Patients Undergoing an ERCP in Four Different Countries

Launched by MARCO J. BRUNO · Mar 28, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how common it is for patients undergoing a specific medical procedure called Endoscopic Retrograde Cholangiopancreatography (ERCP) to carry bacteria that are resistant to multiple drugs. This is important because the tools used in this procedure, called duodenoscopes, can sometimes still have harmful bacteria on them, even after cleaning. The trial will take place in four countries: India, the Netherlands, Italy, and the United States. By understanding how many patients carry these resistant bacteria, healthcare providers can better decide when to use single-use duodenoscopes, which are designed to be used only once, to help prevent the spread of infection.

To be eligible for the study, participants must be scheduled for an ERCP procedure and be able to understand and agree to take part in the trial. The researchers want to know not only how many patients have these resistant bacteria but also if the duodenoscopes themselves are contaminated and if there’s a risk of spreading bacteria through their use. Participants can expect to contribute to important research that may improve safety in medical procedures in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The subject is planned to undergo an ERCP procedure, either through an outpatient department or an inpatient department
• • The subject is capable to understand the information required to give informed consent
• Exclusion Criteria:
• • In case the inclusion criteria were not met